Organisation paid for research Program year 2022 Source: CMS Open Payments

Advanced Clinical Trials

Neither a doctor nor a teaching hospital

Research payments

$172,651

46 payments

Through program year 2022, Advanced Clinical Trials is reported as receiving $172,651 in research payments, across 46 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2022	Research	$55,455	7
2021	Research	$1,050	2
2020	Research	$44,458	7
2019	Research	$71,689	30

Breakdown

Who paid Research payments · program years 2019–2022

Pfizer Inc. $171,224 45 payments
Novartis Pharmaceuticals Corporation $1,427 1 payment

Studies the money was for Research payments · program years 2019–2022

A Phase 3 Placebocontrolled Randomized Observerblinded Study to Evaluate the Efficacy Safety and Tolerability of A Clostridium Difficile Vaccine in Adults 50 Years of Age and Older $171,224 45 payments
A Randomized Double Blind Placebo Controlled Event Driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post Myocardial Infarction Patients With Elevated Hscrp $1,427 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.